Insulin-binding protein-5 down-regulates the balance of Th17/Treg

• Published in: Frontiers in immunology Vol. 13; p. 1019248
• Main Authors: Zhu, Mengyuan, Han, Han, Hu, Lei, Cao, Yu, Fan, Zhipeng
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 01.11.2022
• Subjects: immune homeostasis; Immunology; inflammation response; inflammatory diseases; insulin-binding protein-5; Th17
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.1019248

The inflammatory response plays critical important role in tissue hemostasis. Our previous study showed insulin-binding protein-5 (IGFBP5) could enhance the regeneration of tissue defect under inflammation condition, but the function of IGFBP5 in controlling inflammation and regulating immune responses remains unclear. In present study, we studied the regulatory effect of IGFBP5 on T cell immune response in vitro , and the maintenance of Th17/Treg balance in vivo by using dextran sulfate sodium salt (DSS)-induced colitis in mice. The results showed that IGFBP5 inhibited the differentiation of CD4 + T cells into Th17 subset while promoted its differentiation into Treg subsets. Further results of animal experiments demonstrated that recombinant IGFBP5 reversed the imbalance of Th17/Treg and alleviated the severity of DSS-induced colitis. The percentage of Th17 cells decreased and the percentage of Treg cells increased in the inflamed colon tissue and mesenteric lymph nodes of mice with colitis after IGFBP5 treatment. Besides, pro-inflammatory cytokines such as TNF-α, IL-1β and IFN-γ in serum were suppressed after the treatment of IGFBP5. Moreover, the function of IGFBP5 in regulating Th17/Treg balance could be inhibited by the inhibitors of ERK or JNK pathway. In conclusion, all these data showed that IGFBP5 could regulate Th17/Treg balance via ERK or JNK pathways. The findings of our study provide a theoretical basis for the application of IGFBP5 in inflammatory diseases.